• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » IBM Watson Health to aid in matching cancer patients to clinical trials

IBM Watson Health to aid in matching cancer patients to clinical trials

June 8, 2016 By Mark Hollmer

IBM WatsonIBM‘s (NYSE:IBM) famed Watson artificial intelligence platform will be put to use to help match cancer patients with clinical trials.

The Armonk, N.Y.-based technology giant said Froedtert & the Medical College of Wisconsin Network will adopt the Watson technology for this purpose in a project set to begin this fall. Froedtert/MCW Cancer Network are among the 1st cancer programs nationally to use the technology, according to IBM.

Doctors typically try to match patients to genetically ideal clinical trials that are also the most relevant in the development spectrum. This can be a long process on multiple levels, involving reviews by clinical coordinators who manually sort through patient records and conditions. The idea is that Watson could hasten the process by analyzing a greater amount of information in less time, including patients’ unique genetic details.

“No 2 people and no 2 cancers are alike,” Dr. James Thomas, oncologist and medical director with Froedtert & MCW Cancer Clinical Trials Office & Translational Research Unit, said in prepared remarks. “Watson will support a higher level of personalized care for our patients by enabling us to securely connect individual health information with a vast array of clinical trials.”

There’s also a potential care gap to fill here. About 13.8 million Americans are currently battling cancer. There are also approximately 53,000 cancer clinical trials going nationally at any given time, according to ClinicalTrials.gov data cited by IBM.

Watson is increasingly being used in multiple medical endeavors. Medtronic (NYSE:MDT) is partnering with Watson, for example, to improve diabetes care; Johnson & Johnson (NYSE:JNJ) is using the technology to improve outcomes for knee replacement surgeries.

IBM launched IBM Watson Health and the Watson Health Cloud platform in 2015. The unit works with doctors, researchers and insurers in a bid to use data to achieve new healthcare innovations.

Filed Under: Big Data, Clinical Trials, Oncology Tagged With: IBM

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy